Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leena Joseph

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape projectErnst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Nature|April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature|December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape projectErnst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Nature|April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature|December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Pageof 8